This pilot clinical trial studies how well a head and neck maskless immobilization device works in immobilizing patients with head and neck cancer or intracranial tumors undergoing radiation therapy. Maskless immobilization device may help to prevent movement of head during radiation therapy and immobilize patients with the same accuracy and reliability as the standard thermoplastic mask routinely used for patients with brain tumors receiving radiation therapy.
Additional locations may be listed on ClinicalTrials.gov for NCT03076255.
See trial information on ClinicalTrials.gov for a list of participating sites.
PRIMARY OBJECTIVE:
I. To assess the setup accuracy and reproducibility of the maskless immobilization device (MID) in patients being treated for head and neck cancers or intracranial tumors who require radiation therapy.
SECONDARY OBJECTIVE:
I. To assess the patient comfort and quality of life with the MID compared to the thermoplastic mask.
OUTLINE:
Patients undergo computed tomography (CT) simulation with thermoplastic mask and MID for radiation therapy (RT) planning on day 1. Patients undergo standard of care RT using thermoplastic mask only and cone-beam computed tomography (CBCT) imaging with thermoplastic mask and MID on days 8 and 15.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationThomas Jefferson University Hospital
Principal InvestigatorVoichita Bar Ad
